Skip to main content
Log in

Intrauterine levonorgestrel cost effective for preventing cancer

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2019 Canadian dollars

Reference

  • Bernard L, et al. The levonorgestrel intrauterine system for prevention of endometrial cancer in women with obesity: A cost-effectiveness study. Gynecologic Oncology : 26 Feb 2021. Available from: URL: http://doi.org/10.1016/j.ygyno.2021.02.020

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Intrauterine levonorgestrel cost effective for preventing cancer. PharmacoEcon Outcomes News 874, 19 (2021). https://doi.org/10.1007/s40274-021-7562-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7562-x

Navigation